Related Experiment Videos

Altered calcium metabolism in epileptic children on anticonvulsants

British Medical Journal
|October 23, 1971
PubMed

Insights

Anticonvulsant drugs in epileptic children can disrupt vitamin D metabolism, leading to low calcium levels. This study highlights the increased vitamin D needs in these patients.

Area of Science:

  • Pediatric Endocrinology
  • Clinical Pharmacology
  • Nutritional Biochemistry

Background:

  • Anticonvulsant drugs are widely used in epilepsy management.
  • Long-term anticonvulsant therapy has been associated with potential metabolic disturbances.
  • Vitamin D deficiency and hypocalcemia have been reported in patients on these medications.

Purpose of the Study:

  • To investigate the effects of anticonvulsant drugs on calcium and vitamin D metabolism in epileptic children.
  • To assess the prevalence of biochemical abnormalities indicative of altered vitamin D metabolism.
  • To explore the relationship between hepatic enzyme induction and serum calcium levels.

Main Methods:

  • Survey of 105 epileptic children (aged 10-16 years) on anticonvulsant drugs.
  • Measurement of serum calcium and alkaline phosphatase levels.
  • Quantification of urinary D-glucaric acid excretion as an index of hepatic enzyme induction.

Main Results:

  • Reduced serum calcium observed in 30% of children.
  • Elevated serum alkaline phosphatase found in 24% of children.
  • Increased urinary D-glucaric acid excretion (indicating liver enzyme induction) in 94% of children, with an inverse correlation to serum calcium levels.

Conclusions:

  • Anticonvulsant-induced hepatic enzyme induction significantly alters vitamin D metabolism in epileptic children.
  • This alteration leads to increased vitamin D requirements, potentially causing hypocalcemia and osteomalacia.
  • Average dietary vitamin D intake in Britain may be insufficient to meet the increased needs of these children.

Related Concept Videos